Download Files:
Disufenton sodium
SKU
HY-13244-10 mg
Category Reference compound
Tags Immunology/Inflammation;Metabolic Enzyme/Protease;NF-κB, Neurological Disease, Reactive Oxygen Species
$48 – $480
Products Details
Product Description
– Disufenton sodium (NXY-059) is a derivative of the neuroprotective agent phenylbutynitrone and has extremely strong free radical scavenging ability.
Web ID
– HY-13244
Storage Temperature
– 4°C (Powder, sealed storage, away from moisture)
Shipping
– Room Temperature
Applications
– Neuroscience-Neurodegeneration
Molecular Formula
– C11H13NNa2O7S2
References
– [1]Kuroda S, et al. Neuroprotective effects of a novel nitrone, NXY-059, after transient focal cerebral ischemia in the rat. J Cereb Blood Flow Metab, 1999, 19(7), 778-787.|[2]Marshall JW, et al. NXY-059, a free radical–trapping agent, substantially lessens the functional disability resulting from cerebral ischemia in a primate species. Stroke, 2001, 32(1), 190-198.|[3]Culot M, et al. Cerebrovascular protection as a possible mechanism for the protective effects of NXY-059 in preclinical models: an in vitro study. Brain Res, 2009, 19(1294), 144-152.
CAS Number
– 168021-79-2
Molecular Weight
– 381.33
Compound Purity
– 98.0
SMILES
– O=S(C1=C(C=CC(S(=O)(O[Na])=O)=C1)/C=[N+]([O-])/C(C)(C)C)(O[Na])=O
Clinical Information
– Phase 3
Research Area
– Neurological Disease
Solubility
– DMSO : 125 mg/mL (ultrasonic)|H2O : ≥ 50 mg/mL
Target
– Reactive Oxygen Species
Pathway
– Immunology/Inflammation;Metabolic Enzyme/Protease;NF-κB
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.